Phase I/II Study of Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R(2)) In Primary Effusion Lymphoma or KSHV-Associated Large Cell Lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 23 May 2017
At a glance
- Drugs Lenalidomide (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Prednisolone; Rituximab; Vincristine
- Indications B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 08 Apr 2017 Status changed from not yet recruiting to recruiting.
- 20 Jan 2017 Planned initiation date changed from 1 Sep 2016 to 15 Sep 2016.
- 30 Sep 2016 New trial record